Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-β1 in airway fibroblasts in asthma.

dc.contributor.author

Firszt, Rafael

dc.contributor.author

Francisco, Dave

dc.contributor.author

Church, Tony D

dc.contributor.author

Thomas, Joseph M

dc.contributor.author

Ingram, Jennifer L

dc.contributor.author

Kraft, Monica

dc.date.accessioned

2022-07-01T15:03:41Z

dc.date.available

2022-07-01T15:03:41Z

dc.date.issued

2014-02

dc.date.updated

2022-07-01T15:03:40Z

dc.description.abstract

Airway remodelling is a feature of asthma that contributes to loss of lung function. One of the central components of airway remodelling is subepithelial fibrosis. Interleukin (IL)-13 is a key T-helper 2 cytokine and is believed to be the central mediator of allergic asthma including remodelling, but the mechanism driving the latter has not been elucidated in human asthma. We hypothesised that IL-13 stimulates collagen type-1 production by the airway fibroblast in a matrix metalloproteinase (MMP)- and transforming growth factor (TGF)-β1-dependent manner in human asthma as compared to healthy controls. Fibroblasts were cultured from endobronchial biopsies in 14 subjects with mild asthma and 13 normal controls that underwent bronchoscopy. Airway fibroblasts were treated with various mediators including IL-13 and specific MMP-inhibitors. IL-13 significantly stimulated collagen type-1 production in asthma compared to normal controls. Inhibitors of MMP-2 significantly attenuated collagen production in asthma but had no effect in normal controls. IL-13 significantly increased total and active forms of TGF-β1, and this activation was blocked using an MMP-2 inhibitor. IL-13 activated endogenous MMP-2 in asthma patients as compared to normal controls. In an ex vivo model, IL-13 potentiates airway remodelling through a mechanism involving TGF-β1 and MMP-2. These effects provide insights into the mechanism involved in IL-13-directed airway remodelling in asthma.

dc.identifier

09031936.00068712

dc.identifier.issn

0903-1936

dc.identifier.issn

1399-3003

dc.identifier.uri

https://hdl.handle.net/10161/25436

dc.language

eng

dc.publisher

European Respiratory Society (ERS)

dc.relation.ispartof

The European respiratory journal

dc.relation.isversionof

10.1183/09031936.00068712

dc.subject

Bronchi

dc.subject

Fibroblasts

dc.subject

Humans

dc.subject

Asthma

dc.subject

Collagen Type I

dc.subject

Actins

dc.subject

Transforming Growth Factor beta

dc.subject

Extracellular Matrix Proteins

dc.subject

Interleukin-13

dc.subject

Respiratory Function Tests

dc.subject

Biopsy

dc.subject

Gene Expression Regulation

dc.subject

Adult

dc.subject

Female

dc.subject

Male

dc.subject

Matrix Metalloproteinase 2

dc.title

Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-β1 in airway fibroblasts in asthma.

dc.type

Journal article

duke.contributor.orcid

Ingram, Jennifer L|0000-0002-5269-8864

pubs.begin-page

464

pubs.end-page

473

pubs.issue

2

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Faculty

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Surgery

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.organisational-group

Surgery, Surgical Sciences

pubs.publication-status

Published

pubs.volume

43

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
rcmb.2014-0290oc.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
Description:
Published version